Dov Kadmon
Overview
Explore the profile of Dov Kadmon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
830
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinojosa-Gonzalez D, Saffati G, Kronstedt S, La T, Chiu C, Wahlstedt E, et al.
J Robot Surg
. 2024 Apr;
18(1):177.
PMID: 38630430
Lymphocele is one of the most common complications after radical prostatectomy. Multiple authors have proposed the use of vessel sealants or peritoneal interposition techniques as preventive interventions. This study aimed...
2.
Hinojosa-Gonzalez D, Nolazco J, Saffati G, Kronstedt S, Jones J, Kadmon D, et al.
Eur Urol Focus
. 2024 Jan;
10(2):234-241.
PMID: 38242825
Context: Some authors propose extended pelvic lymph node dissection (ePLND) to enhance diagnostic and therapeutic outcomes in patients with localized prostate cancer. However, recent evidence found no difference in biochemical...
3.
Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, et al.
Prostate
. 2017 Nov;
78(2):128-139.
PMID: 29131367
Background: Nerves are key factors in prostate cancer (PCa), but the functional role of innervation in prostate cancer is poorly understood. PCa induced neurogenesis and perineural invasion (PNI), are associated...
4.
De Vivar A, Sayeeduddin M, Rowley D, Cubilla A, Miles B, Kadmon D, et al.
Hum Pathol
. 2017 Mar;
63:202-211.
PMID: 28315427
Prostatic carcinoma, like many other carcinomas, generates a stromal reaction. This phenomenon is well established in the scientific literature. The normal parenchymal smooth muscle phenotype switches to a myofibroblastic phenotype...
5.
Ding Y, He D, Florentin D, Frolov A, Hilsenbeck S, Ittmann M, et al.
Clin Cancer Res
. 2013 Oct;
19(22):6101-11.
PMID: 24097862
Background: Semaphorin 4F (S4F) has roles in embryologic axon guidance and is expressed in adults. S4F is involved in cancer-induced neurogenesis. Methods: Prostate cells were transfected with S4F retrovirus. Cells...
6.
Sonpavde G, Wang M, Peterson L, Wang H, Joe T, Mims M, et al.
Invest New Drugs
. 2013 Apr;
32(2):235-242.
PMID: 23609828
Background: Given the immunogenicity of NY-ESO-1 peptides in prostate cancer, a phase I clinical trial was designed to evaluate HLA class-I and class-II restricted NY-ESO-1 peptides in metastatic castration-resistant prostate...
7.
Sonpavde G, Thompson T, Jain R, Ayala G, Kurosaka S, Edamura K, et al.
Clin Cancer Res
. 2011 Sep;
17(22):7174-82.
PMID: 21933889
Background: GLIPR1 is upregulated by p53 in prostate cancer cells and has preclinical antitumor activity. A phase I clinical trial was conducted to evaluate the safety and activity of the...
8.
Ayala G, Muezzinoglu B, Hammerich K, Frolov A, Liu H, Scardino P, et al.
Am J Pathol
. 2011 Jan;
178(1):79-87.
PMID: 21224046
We previously reported that reactive stroma grading in prostate cancer (PCa) is predictive of biochemical recurrence in prostatectomies and biopsies. In this study, we tested whether quantifying the percentage of...
9.
Ayala G, Dai H, Powell M, Li R, Ding Y, Wheeler T, et al.
Clin Cancer Res
. 2008 Dec;
14(23):7593-603.
PMID: 19047084
Purpose: Perineural invasion is the only interaction between cancer cells and nerves studied to date. It is a symbiotic relationship between cancer and nerves that results in growth advantage for...
10.
Ayala G, Yan J, Li R, Ding Y, Thompson T, Mims M, et al.
Clin Cancer Res
. 2008 Nov;
14(22):7511-8.
PMID: 19010869
Purpose: To assess the safety of administering bortezomib to patients undergoing a radical prostatectomy, to assess pathologic changes induced by bortezomib in prostate cancer specimen, and to verify alterations by...